M H Medicus Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 18-07-2024
- Paid Up Capital ₹ 0.50 M
as on 18-07-2024
- Company Age 20 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.50 Cr
as on 18-07-2024
- Revenue 9.08%
(FY 2023)
- Profit -7.50%
(FY 2023)
- Ebitda -6.65%
(FY 2023)
- Net Worth 12.20%
(FY 2023)
- Total Assets -4.14%
(FY 2023)
About M H Medicus
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.50 M.
The company currently has active open charges totaling ₹1.50 Cr.
Harpreet Arora, Rajan Chatterjee, and Lakhvinder Arora serve as directors at the Company.
- CIN/LLPIN
U24232DL2004PTC126422
- Company No.
126422
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
18 May 2004
- Date of AGM
29 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
New Delhi, Delhi, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at M H Medicus?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Harpreet Arora  | Director | 18-May-2004 | Current |
| Rajan Chatterjee | Director | 18-May-2004 | Current |
| Lakhvinder Arora | Director | 18-May-2004 | Current |
Financial Performance of M H Medicus.
M H Medicus Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 9.08% increase. The company also saw a slight decrease in profitability, with a 7.5% decrease in profit. The company's net worth Soared by an impressive increase of 12.2%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of M H Medicus?
In 2022, M H Medicus had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Novopharm Life Sciences Private LimitedActive 22 years 10 monthsHarpreet Arora and Lakhvinder Arora are mutual person
- Novomax Pharma Private LimitedActive 12 years 5 months
Harpreet Arora, Rajan Chatterjee and 1 more are mutual person
- Panchdeep Medi-Care Private Limited.Active 32 years 11 months
Harpreet Arora and Lakhvinder Arora are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 18 Sep 2021 | ₹1.50 Cr | Open |
How Many Employees Work at M H Medicus?
M H Medicus has a workforce of 26 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of M H Medicus, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped M H Medicus's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
